IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

Predictors in ordinal regression model for GDS. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Classification of hand grip strength. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Rating scale for functional severity [28]. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Regression model coefficients. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

ICOPE screening positive participant’s responses. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

WHO BMI classification for adults. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Histogram of the extracted parameters. by Qiuyu Du (20760848)

“…No significant associations were found with long-term outcomes.…”

S1 File - by Zsófia Tróznai (19923854)

“…Measurements of body size, body composition (InBody 720), and bone age were performed in all players who were selected to participate in the selection program (<i>n</i> = 264) (mean±sd age: 13.1±0.6 years) and in a sample of not-selected players (<i>n</i> = 266) (mean±sd age: 13.2±0.6 years). …”

Flowchart of the selection program. by Zsófia Tróznai (19923854)

“…Measurements of body size, body composition (InBody 720), and bone age were performed in all players who were selected to participate in the selection program (<i>n</i> = 264) (mean±sd age: 13.1±0.6 years) and in a sample of not-selected players (<i>n</i> = 266) (mean±sd age: 13.2±0.6 years). …”

Fig 5 - by Varun Tiwari (9258130)

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). by Amoura M. Abou-El-Naga (21001524)